Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methicillin-resistant Staphylococcus aureus disease in three communities.
Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Fridkin SK, et al. N Engl J Med. 2005 Apr 7;352(14):1436-44. doi: 10.1056/NEJMoa043252. N Engl J Med. 2005. PMID: 15814879 Free article.
Antimicrobial resistance in intensive care units.
Fridkin SK, Gaynes RP. Fridkin SK, et al. Clin Chest Med. 1999 Jun;20(2):303-16, viii. doi: 10.1016/s0272-5231(05)70143-x. Clin Chest Med. 1999. PMID: 10386258 Review.
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals. Fridkin SK, et al. Ann Intern Med. 2001 Aug 7;135(3):175-83. doi: 10.7326/0003-4819-135-3-200108070-00009. Ann Intern Med. 2001. PMID: 11487484 Free article.
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.
Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA; Anthrax Bioterrorism Investigation Team. Jernigan JA, et al. Among authors: fridkin sk. Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44. doi: 10.3201/eid0706.010604. Emerg Infect Dis. 2001. PMID: 11747719 Free PMC article.
Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
Hageman JC, Pegues DA, Jepson C, Bell RL, Guinan M, Ward KW, Cohen MD, Hindler JA, Tenover FC, McAllister SK, Kellum ME, Fridkin SK. Hageman JC, et al. Among authors: fridkin sk. Emerg Infect Dis. 2001 Nov-Dec;7(6):1023-5. doi: 10.3201/eid0706.010618. Emerg Infect Dis. 2001. PMID: 11747733 Free PMC article.
Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci.
Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP; Intensive Care Antimicrobial Resistance Epidemiology Project; National Nosocomial Infections Surveillance Systems Hospitals. Fridkin SK, et al. Emerg Infect Dis. 2002 Jul;8(7):702-7. doi: 10.3201/eid0807.010465. Emerg Infect Dis. 2002. PMID: 12095438 Free PMC article.
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Fridkin SK, et al. Clin Infect Dis. 2003 Feb 15;36(4):429-39. doi: 10.1086/346207. Epub 2003 Jan 31. Clin Infect Dis. 2003. PMID: 12567300
181 results